Revelation Biosciences Warrant
REVBW
13 hedge funds and large institutions have $18.6K invested in Revelation Biosciences Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
7.3% less ownership
Funds ownership: 82.93% → 75.62% (-7.3%)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
89% less capital inflows, than outflows
Capital inflows: $221 | Capital outflows: $2K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
+$221 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Privium Fund Management
Amsterdam,
Netherlands
|
-$752 |
| 2 |
Wolverine Asset Management
Chicago,
Illinois
|
-$700 |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$292 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$230 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29 |
REVBW Hedge Fund Activity: Q3 2024 in Review
13 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2024, worth a combined $18.6K — down 28% from $25.9K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBW and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $221. The largest seller was Privium Fund Management, exiting entirely with an estimated $752 sold.
- 13 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $18.6K of Revelation Biosciences Warrant stock for Q3 2024, down 28% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Revelation Biosciences Warrant buyer in Q3 2024 was Two Sigma Securities, an estimated $221 added.
- The largest Revelation Biosciences Warrant seller in Q3 2024 was Privium Fund Management, an estimated $752 sold.
Based on aggregated 13F filings for Q3 2024.